Illicit drug use in seven Latin American countries: critical perspectives of families and familiars

Revista Latino-Americana de Enfermagem

Jaqueline Da Silva²  Carla Aparecida Arena Ventura¹  Octavio Muniz Da Costa Vargens¹  Cristina Maria Douat Loyola¹  Daniel Gonzalo Eslava Albarracín¹  Jorge Diaz¹  Gladys Magdalena Rodríguez Funes¹  Mabell Granados Hernández¹  Ruth Magdalena Gallegos Torres¹  Ruth Jakeline Oviedo Rodriguez¹ 

[1] ,Universidade Federal do Rio de Janeiro Escola de Enfermagem Anna Nery ,Brazil

关键词: street drugs;    substance-related disorders;    risk factors;    protection;    family;    friends;    health services accessibility;    Latin America;    multicenter study;    drogas ilícitas;    trastornos relacionados con sustancias;    factores de riesgo;    protección;    familia;    amigos;    accesibilidad a los servicios de salud;    América Latina;    estudio multicéntrico;    drogas ilícitas;    transtornos relacionados ao uso de substâncias;    fatores de risco;    proteção;    família;    amigos;    acesso aos serviços de saúde;    América Latina;    estudo multicêntrico;   

DOI  :  10.1590/S0104-11692009000700002

来源: SciELO

【 摘 要 】

This cross-sectional multi-centre study explored how family members and friends of illicit drug users perceived protective and risk factors, treatment facilities and policies and laws regarding illicit drug use. Family members and friends of illicit drug users were recruited in 10 urban health care outpatient units in 7 Latin American countries (Brazil, Colombia, Costa Rica, Ecuador, Guatemala, Honduras and Mexico) to complete a questionnaire. The majority of the respondents chose psycho-social factors over genetic or biological explanations as causes of drug problems. Respondents felt that families and governments were responsible for preventing drug problems. Church/religious institutions were most often mentioned in the context of accessible treatment. When asked about access to treatment facilities, the majority said that there were not enough. Shame about drug use, cost, and limited treatment options were most often cited as barriers to treatment.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License